You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

100 search results for: expert insights

The Heterogeneity of Underlying Inflammation in Patients With COPD
expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

Pulmonology
Join global expert Professor Ian Pavord as he discusses the heterogeneity of underlying inflammation in patients with COPD.
View more
The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers
expert video

The Multidimensional Impact of Atopic Dermatitis on Children and Their Caregivers

Dermatology
Discover the multidimensional impact of pediatric atopic dermatitis on children and caregivers – a soundbite from the Expert Lounge Canada 2022.
View more
The Burden of Atopic Dermatitis in Children – Daily Pruritis and Sleep Disturbance 
expert video

The Burden of Atopic Dermatitis in Children – Daily Pruritis and Sleep Disturbance 

Dermatology
Dr. Mark Koh provides insights on itch and its impact on sleep in children with AD.
View more
The Role of Chronic Inflammation in the Pathogenesis of CSU
expert video

The Role of Chronic Inflammation in the Pathogenesis of CSU

Dermatology
Drs. Kim and Saini discuss the role of chronic inflammation in the pathogenesis of CSU in this insightful interview.
View more
The Role of Type 2 Inflammation in Moderate-to-Severe AD
expert video

The Role of Type 2 Inflammation in Moderate-to-Severe AD

Dermatology
In this expert interview video focusing on topics from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, Dr. Stephan Weidinger discusses how type 2 inflammation contributes to the systemic inflammation seen in patients with moderate-to-severe AD.
View more
Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
Current Treatment Options are not Effective for Achieving Full Disease Control in All Patients with CSU
expert video

Current Treatment Options are not Effective for Achieving Full Disease Control in All Patients with CSU

Dermatology
Dr. Casale presents the data on the use of antihistamines at licensed doses, indicating that only a minority achieve disease control.
View more
Neuroiflammation and Neurogenic Itch in Prurigo Nodularis
expert video

Neuroiflammation and Neurogenic Itch in Prurigo Nodularis

Dermatology
Dr. Chovatiya discusses the neuroinflammatory mechanisms of PN.
View more
Can Early Intervention Shape the Course of Atopic Dermatitis?
expert video

Can Early Intervention Shape the Course of Atopic Dermatitis?

Dermatology
Dr. Paller presents highlights from recent clinical studies in AD, which highlight the potential benefits of early and effective AD treatment in modifying disease progression and mitigating atopic comorbidities.
View more
Factors Associated With Development of Atopic Comorbidities in AD
expert video

Factors Associated With Development of Atopic Comorbidities in AD

Dermatology
Dr. Paller discusses factors influencing AD chronicity and comorbidities, focusing on disease severity, early onset, heredity, multiple allergies, and urban living as important in evaluating AD’s lasting effects on children.
View more
Most Children With Atopic Dermatitis Have Uncontrolled Disease
expert video

Most Children With Atopic Dermatitis Have Uncontrolled Disease

Dermatology
Examine evidence from PEDI-BURDEN for the risk of flares in children with moderate-to-severe atopic dermatitis – a short soundbite from EADV 2022.
View more
Itch: Neuroimmune Axis in Chronic Pruritic Skin Diseases
expert video

Itch: Neuroimmune Axis in Chronic Pruritic Skin Diseases

Dermatology
Dr. Weidinger discusses the intricate neuroinflammatory mechanisms of chronic pruritic skin disease such as AD and PN.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AustraliaChange country/region